{"id":"https://openalex.org/W2011553445","doi":"https://doi.org/10.1016/j.ejps.2015.04.010","title":"The similarity question for biologicals and non-biological complex drugs","display_name":"The similarity question for biologicals and non-biological complex drugs","publication_year":2015,"publication_date":"2015-04-25","ids":{"openalex":"https://openalex.org/W2011553445","doi":"https://doi.org/10.1016/j.ejps.2015.04.010","mag":"2011553445","pmid":"https://pubmed.ncbi.nlm.nih.gov/25912826"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejps.2015.04.010","doi":"https://doi.org/10.1016/j.ejps.2015.04.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejps.2015.04.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0928098715001530/pdf","source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0928098715001530/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022480241","display_name":"Daan J.A. Crommelin","orcid":"https://orcid.org/0000-0003-0216-5039","observed_orcids":["https://orcid.org/0000-0003-0216-5039"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Daan J.A. Crommelin","raw_affiliation_strings":["Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, UIPS, Utrecht University, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, UIPS, Utrecht University, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108461895","display_name":"Vinod P. Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vinod P. Shah","raw_affiliation_strings":["North Potomac, MD 20878, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Potomac, MD 20878, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019165393","display_name":"Imre Klebovich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Imre Klebovich","raw_affiliation_strings":["Semmelweis University, Department of Pharmaceutics, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis University, Department of Pharmaceutics, Budapest, Hungary","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020993025","display_name":"Scott E. McNeil","orcid":"https://orcid.org/0000-0002-7575-5198","observed_orcids":["https://orcid.org/0000-0002-7575-5198","https://orcid.org/0000-0001-7035-075X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott E. McNeil","raw_affiliation_strings":["Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004540049","display_name":"Vera Weinstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Vera Weinstein","raw_affiliation_strings":["Teva Pharmaceutical Industries, Ltd., Discovery and Product Development, Global Research and Development, Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries, Ltd., Discovery and Product Development, Global Research and Development, Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037316005","display_name":"Beat Fl\u00fchmann","orcid":"https://orcid.org/0000-0002-3077-298X","observed_orcids":["https://orcid.org/0000-0002-3077-298X"]},"institutions":[{"id":"https://openalex.org/I4210102083","display_name":"Vifor Pharma (Switzerland)","ror":"https://ror.org/0185z7g17","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210102083"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Beat Fl\u00fchmann","raw_affiliation_strings":["Vifor Fresenius Medical Care Renal Pharma Ltd., Glattbrugg, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vifor Fresenius Medical Care Renal Pharma Ltd., Glattbrugg, Switzerland","institution_ids":["https://openalex.org/I4210102083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071198933","display_name":"Stefan M\u00fchlebach","orcid":"https://orcid.org/0000-0002-8471-7513","observed_orcids":["https://orcid.org/0000-0002-8471-7513"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I4210102083","display_name":"Vifor Pharma (Switzerland)","ror":"https://ror.org/0185z7g17","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210102083"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Stefan M\u00fchlebach","raw_affiliation_strings":["Vifor Pharma Ltd, Glattbrugg, Switzerland; Dept. Pharmaceutical Sciences, Unit of Clinical Pharmacy and Epidemiology, University of Basel, Switzerland","Dept. Pharmaceutical Sciences, Unit of Clinical Pharmacy and Epidemiology, University of Basel, Switzerland","Vifor Pharma Ltd, Glattbrugg, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vifor Pharma Ltd, Glattbrugg, Switzerland; Dept. Pharmaceutical Sciences, Unit of Clinical Pharmacy and Epidemiology, University of Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I4210102083"]},{"raw_affiliation_string":"Dept. Pharmaceutical Sciences, Unit of Clinical Pharmacy and Epidemiology, University of Basel, Switzerland","institution_ids":["https://openalex.org/I1850255"]},{"raw_affiliation_string":"Vifor Pharma Ltd, Glattbrugg, Switzerland","institution_ids":["https://openalex.org/I4210102083"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070250753","display_name":"Jon S. B. de Vlieger","orcid":"https://orcid.org/0000-0002-9291-3549","observed_orcids":["https://orcid.org/0000-0002-9291-3549"]},"institutions":[{"id":"https://openalex.org/I4210109246","display_name":"Top Institute Pharma","ror":"https://ror.org/01qmxzb47","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210109246"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jon S.B. de Vlieger","raw_affiliation_strings":["Dutch Top Institute Pharma, P.O. Box 142, 2300 AC Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dutch Top Institute Pharma, P.O. Box 142, 2300 AC Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210109246"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5022480241"],"corresponding_institution_ids":["https://openalex.org/I193662353"],"apc_list":{"value":3070,"currency":"USD","value_usd":3070},"apc_paid":{"value":3070,"currency":"USD","value_usd":3070},"fwci":4.3554,"has_fulltext":true,"cited_by_count":72,"citation_normalized_percentile":{"value":0.95183342,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"76","issue":null,"first_page":"10","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/similarity-analysis","display_name":"similarity analysis","score":0.6140000224113464},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmaceutical-equivalence","display_name":"pharmaceutical equivalence","score":0.7559999823570251},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9629999995231628},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.6880000233650208},{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":0.6169999837875366},{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.9620000123977661},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.7889999747276306},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.671999990940094},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9122722744941711},{"id":"https://openalex.org/C2780565519","wikidata":"https://www.wikidata.org/wiki/Q1208937","display_name":"Multitude","level":2,"score":0.6500820517539978},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.5111363530158997},{"id":"https://openalex.org/C2780069185","wikidata":"https://www.wikidata.org/wiki/Q7977945","display_name":"Equivalence (formal languages)","level":2,"score":0.48487576842308044},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4592047333717346},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.44329845905303955},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.4212897717952728},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.41664573550224304},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3814164400100708},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3491131067276001},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.34314483404159546},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.32026737928390503},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.23673588037490845},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22507792711257935},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.2133907973766327},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.20731565356254578},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.1900494396686554},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.1834380030632019},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.10629874467849731},{"id":"https://openalex.org/C118615104","wikidata":"https://www.wikidata.org/wiki/Q121416","display_name":"Discrete mathematics","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009626","descriptor_name":"Terminology as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D061214","descriptor_name":"Patient Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ejps.2015.04.010","doi":"https://doi.org/10.1016/j.ejps.2015.04.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejps.2015.04.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0928098715001530/pdf","source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:25912826","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25912826","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","raw_type":"Conference Proceedings"},{"id":"pmh:oai:edoc.unibas.ch:72678","doi":null,"is_oa":false,"landing_page_url":"https://edoc.unibas.ch/72678/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401836","display_name":"edoc (University of Basel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1850255","host_organization_name":"University of Basel","host_organization_lineage":["https://openalex.org/I1850255"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.ejps.2015.04.010","doi":"https://doi.org/10.1016/j.ejps.2015.04.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejps.2015.04.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0928098715001530/pdf","source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4000000059604645,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2011553445.pdf","grobid_xml":"https://content.openalex.org/works/W2011553445.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1240392788","https://openalex.org/W1248801782","https://openalex.org/W1540299321","https://openalex.org/W1971014721","https://openalex.org/W1991470371","https://openalex.org/W1997702073","https://openalex.org/W2018028549","https://openalex.org/W2023193839","https://openalex.org/W2023749561","https://openalex.org/W2023807542","https://openalex.org/W2064620980","https://openalex.org/W2080690089","https://openalex.org/W2086438722","https://openalex.org/W2094580354","https://openalex.org/W2100093895","https://openalex.org/W2102656314","https://openalex.org/W2105608359","https://openalex.org/W2125134781","https://openalex.org/W2134380349","https://openalex.org/W2134959109","https://openalex.org/W2142289247","https://openalex.org/W2155591144","https://openalex.org/W2166126901","https://openalex.org/W2172239347","https://openalex.org/W2504512426","https://openalex.org/W4211010877","https://openalex.org/W4235940105","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1918017297","https://openalex.org/W7039613951","https://openalex.org/W2320776272","https://openalex.org/W2317011020","https://openalex.org/W2329875291","https://openalex.org/W2285907969","https://openalex.org/W1993527690","https://openalex.org/W2157966901","https://openalex.org/W7097956060","https://openalex.org/W4323925526"],"abstract_inverted_index":{"For":[0,55],"small":[1,211],"-":[2,6],"low":[3],"molecular":[4],"weight":[5],"molecule":[7],"medicines":[8,44],"a":[9,77,96,132,237],"robust":[10],"regulatory":[11,91,199,226],"system":[12,19],"has":[13,75,85],"evolved":[14],"over":[15],"the":[16,35,46,57,71,89,93,110,116,140,144,149,160,170,178,187,190,195,215,249,254],"years.":[17],"This":[18,74],"guarantees":[20],"high":[21],"and":[22,31,98,158,183,224,230,244,257],"constant":[23],"quality":[24],"of":[25,48,59,66,107,131,135,186,189,198,208],"our":[26],"(generic)":[27],"medicines.":[28],"Pharmaceutical":[29],"equivalence":[30,49],"bioequivalence":[32],"assessment":[33],"are":[34,42,126],"pillars":[36],"under":[37],"that":[38,209],"system.":[39],"But":[40],"there":[41,103],"complex":[43,108,112,133],"where":[45,79,115],"question":[47],"is":[50,104,143,166],"more":[51,216],"challenging":[52],"to":[53,168],"answer.":[54],"biologicals":[56,202],"paradigm":[58,118],"similarity":[60],"rather":[61],"than":[62],"equality":[63],"(the":[64],"emergence":[65],"'biosimilars')":[67],"was":[68],"developed":[69],"in":[70,239,253],"past":[72],"decade.":[73],"been":[76,86],"program":[78],"an":[80],"evolutionary,":[81],"science":[82],"based":[83],"approach":[84],"chosen":[87],"by":[88,155],"frontrunner":[90],"body,":[92],"EMA,":[94],"with":[95],"'learn":[97],"confirm'":[99],"character.":[100],"In":[101],"addition,":[102],"another":[105],"group":[106,188],"drugs,":[109,113],"non-biological":[111],"NBCDs,":[114],"generic":[117],"can":[119],"be":[120,152,214],"challenged":[121],"as":[122,177],"well.":[123],"The":[124,222],"NBCDs":[125,172],"defined":[127],"as:":[128],"1.":[129],"consisting":[130],"multitude":[134,142],"closely":[136],"related":[137],"structures;":[138],"2.":[139],"entire":[141],"active":[145],"pharmaceutical":[146],"ingredient;":[147],"3.":[148],"properties":[150],"cannot":[151],"fully":[153],"characterized":[154],"physicochemical":[156],"analysis":[157],"4.":[159],"consistent,":[161],"tightly":[162],"controlled":[163],"manufacturing":[164],"process":[165],"fundamental":[167],"reproduce":[169],"product.":[171],"encompass":[173],"product":[174],"families":[175],"such":[176],"glatiramoids,":[179],"liposomes,":[180],"iron-carbohydrate":[181],"colloids":[182],"many":[184],"candidates":[185],"upcoming":[191],"nanoparticulate":[192],"systems.":[193],"Following":[194],"main":[196],"principles":[197],"pathways":[200],"for":[201,210,219,228],"(with":[203],"appropriate":[204],"product-by-product":[205],"adjustments),":[206],"instead":[207],"molecules,":[212],"would":[213],"logical":[217],"strategy":[218],"these":[220],"NBCDs.":[221],"status":[223],"outstanding":[225],"issues":[227,250],"biosimilars":[229],"NBCD-similars/follow":[231],"on":[232],"versions":[233],"were":[234],"discussed":[235],"at":[236],"conference":[238],"Budapest,":[240],"Hungary":[241],"(October":[242],"2014)":[243],"this":[245],"commentary":[246],"touches":[247],"upon":[248],"brought":[251],"up":[252],"presentations,":[255],"deliberations":[256],"conclusions.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}